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Role of intrinsic renal cells versus infiltrating cells in glomerular
crescent formation.
Background. Studies were undertaken to characterize the cel-
lular composition that occurs in glomeruli and the tubulointersti-
tium of a passive model of complement-independent crescentic
nephritis in mice.
Methods. Glomerulonephritis was induced by the injection of
antibody to whole rabbit glomeruli, and tissue was examined
histologically at 7, 14 and 28 days.
Results. Mice developed proteinuria, glomerular crescents, and
progressive glomerulosclerosis and tubulointerstitial fibrosis. The
majority of the cells within the crescents appeared to be intrinsic
ezrin-positive epithelial cells of visceral or parietal origin. Many of
the ezrin positive cells were proliferating and expressing the
PDGF receptor. Despite expression of the macrophage adhesive
protein, osteopontin, the early crescents were devoid of infiltrat-
ing macrophages, T cells or myofibroblasts, which could be
explained by the finding that the Bowman’s capsule remained
intact. Tubulointerstitial damage also occurred, and included
tubular dilation and atrophy, periglomerular and patchy intersti-
tial infiltration and interstitial fibrosis with increased interstitial
deposition of type IV collagen and laminin. Interstitial infiltrating
cells included macrophages, CD41 T lymphocytes, CD81 T
lymphocytes, and activated myofibroblasts. Tubular osteopontin
expression was increased in the areas of tubulointerstitial damage
and was associated with interstitial macrophage infiltration.
Conclusions. We describe an experimental model of comple-
ment-independent murine crescentic nephritis associated with
tubulointerstitial injury. Proliferating glomerular epithelial cells
are the main cellular components of the crescents in this model.
Crescentic glomerulonephritis (GN), often called rapidly
progressive glomerulonephritis, refers to a pattern of glo-
merular injury in which there is an extracapillary collection
of cells within Bowman’s capsule that has the appearance
of a ‘crescent’ on histologic cross-section [1]. The presence
of crescents on biopsy is often associated with a deteriora-
tion of renal function over days to weeks, independent of
whether the glomerular injury is initiated by immune
complex, anti-glomerular basement membrane (GBM) an-
tibody or antibody independent mechanisms [1, 2]. Under-
standing the cellular composition and pathogenesis of
crescent formation is therefore of substantial interest.
Experimentally, crescentic nephritis has been most com-
monly induced by antibodies to whole glomeruli (‘nephro-
toxic nephritis’) or to isolated GBM (‘anti-GBM’ disease)
[3–10]. Disease has been induced by active immunization of
glomeruli or GBM, by injecting heterologous anti-GBM
antibody into pre-immunized animals (‘accelerated autolo-
gous’ disease), or by the passive administration of anti-
GBM or anti-glomerular antibody [3–10]. These studies as
well as immunohistochemical studies in humans [11] have
suggested that crescents are composed of both parietal and
visceral glomerular epithelial cells (GEC) as well as infil-
trating monocytes, macrophages, lymphocytes, and later,
fibroblast-like cells [12]. The cellular composition of the
crescents has varied in these studies and may be influenced
by whether or not Bowman’s capsule is intact [13, 14].
In this study, we present a model of passive nephrotoxic
nephritis in mice induced by heterologous antibody to
heterologous glomeruli. These mice develop a relatively
uniform crescentic nephritis in the absence of any light
microscopic evidence of rupture of Bowman’s capsule.
Interestingly, the early development of crescents in this
model appears to involve a proliferation of parietal and
visceral GECs in the absence of detectable macrophage or
lymphocyte infiltration. The increased proliferation ap-
pears to be linked to increased expression of PDGF
receptor (b-subunit) within the crescents. The macrophage
adhesive factor, osteopontin, is also expressed in the cres-
cents and may have a role in the later macrophage infiltra-
tion. These studies suggest that in this model early crescent
formation does not involve a direct macrophage or T-cell
infiltration into Bowman’s space.
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METHODS
Induction of murine crescentic nephrotoxic
glomerulonephritis
Sheep anti-rabbit glomeruli antibody was produced in a
sheep immunized three to four times at two-week intervals
with lyophilized whole rabbit glomeruli emulsified in com-
plete Freud’s adjuvant at the first immunization and in
incomplete Freud’s adjuvant at later immunizations. Rab-
bit glomeruli for immunization were isolated by differential
sieving techniques and contained less than one tubular
fraction per 100 glomeruli. Antisera were heat inactivated
at 56°C for 30 minutes and immune IgG was isolated by
using caprylic acid [15].
Experimental crescentic GN was induced in 15 C57/BL6
mice (Simonsen Laboratories, Gilroy, CA, USA) by intra-
peritoneal injection of sheep anti-rabbit GBM antibody
(0.5 ml/20 g body wt/day for 2 consecutive days). Mice were
sacrificed on days 7, 14, and 28 (N 5 5 at each time point),
and sera and renal biopsies were obtained from each
animal. Controls consisted of normal mice (N 5 6) or mice
injected with equivalent amounts of nonimmune sheep IgG
(N 5 3 at day 7). Biopsies were fixed in either formalin or
methyl Carnoy’s solution and were embedded in paraffin
[16]. For staining of frozen sections, tissue was embedded
in O.C.T. Compound (Miles, Elkart, IN, USA) and rapidly
snap frozen in isopentane in liquid nitrogen as previously
described [16]. Twenty-four-hour urine collections were
performed on days 7, 14, and 28 and analyzed for protein
content by the micro BCA method (Pierce Chemical, IL,
USA).
Immunohistochemistry
To examine renal histology, 4 mm sections were stained
with periodic acid and Schiff’s reagent (PAS) or with methe-
namine-silver. An indirect immunoperoxidase method was
used as previously described [16] to detect a variety of
antigens (Table 1). This included the analysis of prolifer-
ating cells (expressing the proliferating cell nuclear antigen
or PCNA), a-smooth muscle actin (which marks activated
mesangial cells and myofibroblasts [17]), various leukocyte
populations (macrophages, CD4 and CD8 positive T lym-
phocytes and neutrophils), ezrin (an epithelial cell cytoskel-
etal protein) [18], platelet-derived growth factor receptor
Table 1. Antibodies used to detect specific antigens in renal biopsy tissue
Antigen Primary antibodies Second. Antibodies Detection System
Proliferating cell nuclear
antigen (PCNA)
A murine monoclonal IgM against PCNA
(Coulter Immunology, Hialeah, FL,
USA)
A peroxidase-conjugated




(Sigma Chemical CO, St.
Louis, MO, USA)
Ezrin A rabbit polyclonal antibody against ezrin
90/3 (gift from Heinz Furthmayr,
Stanford University School of Medicine,
Stanford, CA, USA)
A biotinylated anti-rabbit IgG
(Vector Laboratories,
Burlingame, CA, USA)
Avidin-biotin system and DAB
a-Smooth muscle actin A monoclonal IgG2a antibody against a-
smooth muscle actin (Sigma)
A peroxidase-conjugated





A rat monoclonal IgG2b antibody against
mouse macrophages (F4/80) (Caltag
Laboratories, Burlingame, CA, USA)
A biotinylated anti-rat IgG (Vector) Avidin-biotin system and DAB
Mouse neutrophils A rat monoclonal IgG2a antibody against
mouse neutrophils (clone 7(4)(Caltag)
A biotinylated anti-rat IgG (Vector) Avidin-biotin system and DAB
CD41 T lymphocytes A rat monoclonal IgG2a antibody against
mouse CD4 antigen (Caltag)
A biotinylated anti-rat IgG (Vector) Avidin-biotin system and DAB
CD81 T lymphocytes A rat monoclonal IgG2a antibody against
mouse CD8a (Ly2) antigen (Caltag)
A biotinylated anti-rat IgG (Vector) Avidin-biotin system and DAB
Osteopontin (OPN) A goat polyclonal antibody against OPN
(OP199; gift from Cecilia M Giachelli,
University of Washington, Seattle, WA,
USA)
A peroxidase-conjugated
monoclonal mouse anti-goat IgG
(Jackson ImmunoResearch






A rabbit antibody against human PDGF-
Rb(7649); (gift from Ronald A Seifert,
University of Washington)
A biotinylated anti-rabbit IgG
(Vector)
Avidin-biotin system and DAB
Type IV collagen A biotinylated rabbit polyclonal antibody
against type IV collagen (Becton





Laminin A biotinylated rabbit polyclonal antibody
against laminin (Chemicon International




All antigens were immunostained using methylcarnoy’s fixed tissue, except that the CD41 and CD81 lymphocytes were stained using acetone-fixed
(10 min) snap frozen tissue.
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(b-subunit) [19], osteopontin (a macrophage adhesive pro-
tein [20], and various extracellular matrix proteins (colla-
gen IV and laminin).
To determine the nature of the proliferating cells in the
crescents, double immunostaining for PCNA and ezrin was
performed. Tissue sections were first stained for PCNA
using the DAB detection system (Table 1) followed by
detection of ezrin using the Vectastain ABC-AP Kit with
Vector Red (Vector Laboratories).
Immunofluorescence
To examine the glomerular binding of the injected
anti-glomerular antibody, and the deposition of comple-
ment, 4 mm frozen sections were stained with FITC-
conjugated antibodies to sheep IgG (Cappel; Organon
Teknika Corp, Durham, NC, USA), mouse IgG (Cappel)
and mouse C3 (Cappel). The presence of fibrin in the
crescents was also examined by staining the tissue for
fibrinogen with FITC-labeled antibody to rat fibrinogen
(cross-reactive with mouse fibrinogen) (Cappel).
Histological assessment of glomerular and
tubulointerstitial injury
In each biopsy, the following histopathological parame-
ters were evaluated in a blinded fashion on PAS-stained
sections: (1) the percentage of glomeruli with crescents, (2)
the percentage of glomeruli with sclerosis, and (3) scoring
of glomerular sclerosis. Glomeruli were considered to
exhibit crescent formation when at least two layers of
non-tubular cells were observed in the Bowman’s space
[21]. Glomerular sclerosis is a histological lesion character-
ized by segmental or global glomerular capillary oblitera-
tion with increased mesangial matrix deposition, intracap-
illary hyaline deposits, and focal or global adhesions of the
capillary tuft into Bowman’s capsule [22]. Scoring of glo-
merular sclerosis utilized five grades: 0 5 normal glomer-
ulus; 11 5 sclerosis involving less than 25% of glomerular
surface area; 2 5 sclerosis involving 25 to 50%; 31 5 50 to
75%; and 41 5 sclerosis involving 75% to 100% of
glomerular surface area. A minimum of 100 glomeruli were
assessed to determine the percentage of crescentic and
sclerotic glomeruli, and the sclerosis score in each animal.
The number of neutrophils, macrophages, CD4 positive
T-cells and CD8 positive T-cells in the glomerular tufts and
the crescents were quantified (as identified by immuno-
staining). At least 100 glomeruli were examined in the
methylcarnoy’s fixed biopsy (used to identify macrophages
and neutrophils) and 30 glomeruli were examined per
acetone-fixed frozen tissue (used to identify T lympho-
cytes).
Tubulointerstitial injury was assessed in PAS stained
tissue by the presence of inflammatory cells within the
interstitium, by the presence of tubular dilation, atrophy,
and cast formation, and by the presence of tubular base-
ment membrane (TBM) thickening and interstitial widen-
ing. Tubulointerstitial inflammation, tubular injury, and
interstitial fibrosis were scored semiquantitatively utilizing
four grades: 0 5 normal interstitium and tubules; 11 5
minimal injury (, 25% of tissue section affected); 21 5
mild injury (25 to , 50% of tissue section affected); 31 5
moderate injury (50 to 75% of tissue section affected); and
41 5 severe injury (. 75% of tissue section involved).
Complement depletion
To examine the role of complement in the development
of glomerular crescents in this model, we induced comple-
ment depletion in a separate group of four mice by
intraperitoneal injections of cobra venom factor (CVF;
1,000 mg/kg body wt) [23] (Diamedix, Miami, FL, USA)
given prior to the first dose of anti-GBM antibody (day 21)
and at day 3 after the second dose of antibody. A second
group of four mice received intraperitoneal saline as con-
trols. At days 3 and 7, sera from CVF-treated and saline-
treated mice were collected for measurement of mouse C3.
Renal biopsies were taken at day 7 of disease and renal
histology was studied as described above.
Mouse C3 levels were measured by radial immunodiffu-
sion [24]. Briefly, goat anti-mouse C3 antibody (CIN, Costa
Mesa, CA, USA) was diluted in 1% agarose made in 0.5 M
veronal buffer and 2-mm wells were punched in the aga-
rose. Sera from CVF-treated and saline-treated mice were
loaded into the wells and the precipitation halos were
measured at 24 hours and compared with dilutions of a
normal mouse serum standard.
Statistical analysis
The percentage of glomeruli exhibiting crescents, the
percentage with sclerosis, and the number of the various
leukocyte populations within the glomerular tuft and cres-
cents are expressed as mean 6 SEM. Comparison between




By direct immunofluorescence, a strong linear pattern of
sheep IgG (41) and mouse IgG (3 to 41) was present
along the GBM with weak (11 to 21) deposition along the
TBM at all time points studied. C3 deposition was present
in a granular pattern at similar sites and the intensity of the
deposition of C3 increased from day 7 to day 14 but
decreased at day 28.
Glomerular changes
After injection of sheep anti-rabbit glomerular antibody,
all animals developed severe glomerular lesions with cres-
cent formation at all time points studied (Table 2 and Fig.
1A). At day 7, segmental and circumferential cellular
crescents were present in 20% to 34% (average 32 6 1.1%)
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of total glomeruli. This was associated with vacuolization of
visceral GECs (podocytes) and segmental parietal GEC
proliferation, resulting in the formation of synechiae, with
adhesion of the glomerular capillary tuft to Bowman’s
capsule. Bowman’s capsules were still intact. Segmental
sclerosis was observed in 15 6 1.8% of total glomeruli (Fig.
1B). Evidence for mesangial cell activation was demon-
strated by the de novo expression of a-smooth muscle actin
by the mesangial cells, and by increased expression of the
PDGF-R b-subunit (Fig. 2). Interestingly, only occasional
infiltrating neutrophils and macrophages were present in
the glomerular tufts (Table 3), but collections of macro-
phages were observed outside the capsules in a periglo-
merular distribution (Fig. 3A).
At days 14 and 28, the percentages of crescentic glomer-
uli were 27.2 6 5% and 29.2 6 3%, respectively (Table 2),
and were not different from day 7. However, there was a
progressive increase over time in the percentage of sclerotic
glomeruli (23 6 5% at day 14, and 35 6 5% at day 28, P ,
0.01) and in the severity of glomerular matrix expansion as
shown by sclerotic indices (2.6 6 0.3 at day 14 and 3.2 6 0.3
at day 28, P , 0.05; Table 2). At day 28, many glomeruli
were obsolescent, and crescents had become more fibro-
cellular.
The induction of glomerular disease with anti-glomerular
antibody was also associated with the development of
proteinuria (Table 4).
Composition of crescents: Proliferating GECs are the
primary cell type
The composition of the cells within the crescents was
examined by immunostaining for various cell types (Table
3). Infiltrating leukocytes (neutrophils, macrophages, and
CD4 positive and CD8 positive T lymphocytes) could not
be identified in the early crescents noted on day 7 and 14
(Fig. 3). In contrast, small numbers of macrophages and
CD4 positive lymphocytes were identified in the crescents
at day 28. No a-smooth muscle actin myofibroblasts could
be identified in crescents at all time points studied.
The observation that the majority of the cells within the
crescents were not leukocytes or a-smooth muscle actin-
positive myofibroblasts suggested that the proliferating
cells were derived from an endogenous cell population
within the glomerulus. Recently, we have identified a
cytoskeletal protein, ezrin, that is expressed by parietal and
visceral GECs in the rat, but not by mesangial and endo-
thelial cells even in the presence of injury or proliferation
[18]. As in the rat, ezrin is expressed by visceral and parietal
GECs in the normal mouse glomerulus (Fig. 3C). In
crescentic GN, the vast majority of the cells within the
crescents were also ezrin-positive (Fig. 3D).
These ezrin-positive cells within the crescents were also
proliferating, as noted by double immunostaining with
PCNA (Fig. 3E). Many of the cells within the crescents also
expressed the b subunit of the PDGF receptor (Fig. 2D),
suggesting that PDGF may be one of the mitogens for
crescent development. Furthermore, the observation that
many of the ezrin-positive cells within the crescents were
Fig. 1. Nephrotoxic nephritis in mice. (A) Acute glomerulonephritis with
crescent formation (arrow) and an intact Bowman’s capsule (day 7,
methenamine silver, 3630). (B) Segmental glomerulosclerosis (day 28,
PAS stain, 3630). (C) Tubulointerstitial changes include tubular dilation
and atrophy, interstitial mononuclear cell infiltration and interstitial
fibrosis (day 7, methenamine silver; 3400).
Table 2. Characteristic histologic features in murine crescentic
nephrotoxic nephritis
Day 7 Day 14 Day 28
Glomerular changes
Crescents (%) 32.4 6 1.14 27.2 6 5.63 29.2 6 3.11
Cellularity (0–41) 111 11 2 111 11
Sclerosis
Sclerotic glomeruli % 14.8 6 1.8 22.8 6 4.8 34.6 6 4.7
Sclerosis score (0–4) 2.4 6 0.2 2.6 6 0.3 3.2 6 0.3
Tubulointerstitial changes
(0–41)
Inflammation 1111 111 2 1111 111 2 1111
Tubular damage 111 111 1111
Fibrosis 0 2 1 0 2 1 11 2 111
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expressing PDGF receptor suggested that these were pari-
etal GECs, for in humans parietal but not visceral GEC
express the PDGF-receptor [25].
The tissue sections were also stained for fibrin. In
contrast to most crescentic models [12, 26], the crescents in
this model were negative for fibrinogen staining except in
rare glomeruli.
Tubulointerstitial changes
Marked tubulointerstitial injury occurred in this model
(Table 2 and Fig. 1C). Early changes included periglomeru-
lar and patchy tubulointerstitial infiltration, tubular dila-
tion, and tubular atrophy. By days 14 and 28, there was an
increasing degree of tubular atrophy and interstitial fibro-
sis. PCNA-positive cells were identified in the areas of
periglomerular and interstitial infiltration (Fig. 4A). The
nature of the cellular infiltrates were studied by immuno-
staining for specific cellular markers. A major component
of the interstitial infiltrates were macrophages (Fig. 4B),
CD41 T lymphocytes (Fig. 4C), and CD81 T lymphocytes.
There was also an increase in number of interstitial myo-
fibroblasts, as shown by the presence of a-smooth muscle
actin-positive cells (Fig. 4D), particularly at day 28. An
increased deposition of collagen IV and laminin, as noted
by immunostaining, was also present in the areas of tubu-
lointerstitial injury (Fig. 4 E, F).
Fig. 2. Expression of a-smooth muscle actin and PDGF b receptor in nephrotoxic nephritis. (A) In the normal mouse, a-smooth muscle actin is
expressed in arterioles with no expression in the glomerular tuft (3400). (B) At day 7 of nephrotoxic nephritis GN there is a marked increase in the
expression of a-smooth muscle actin in the glomerular tuft and periglomerular area (3400). (C) There is minimal mesangial expression of PDGF-Rb
in the normal mouse glomerulus (3630). (D) At day 7 of crescentic GN there is a marked increase in the expression of PDGF-Rb in the glomerular
tuft and in the crescent (3630).
Table 3. Quantitation of PMNs, macrophages, and CD41 and CD81 T lymphocytes in the glomeruli and the glomerular crescents
Normal
glomeruli
Day 7 Day 14 Day 28
Crescents Glomeruli Crescents Glomeruli Crescents Glomeruli
PMNs 0.038 6 0.015 0 6 0 0.262 6 0.093 0 6 0 0.167 6 0.073 0 6 0 0.136 6 0.057
Macrophages 0.023 6 0.001 0 6 0 0.037 6 0.014 0 6 0 0.023 6 0.014 0.052 6 0.023 0.156 6 0.075
CD41 T cells 0.017 6 0.018 0 6 0 0.022 6 0.027 0 6 0 0.028 6 0.025 0.027 6 0.037 0.033 6 0.024
CD81 T cells 0.011 6 0.017 0 6 0 0.017 6 0.018 0 6 0 0.017 6 0.018 0 6 0 0.013 6 0.018
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Increased osteopontin expression in the crescents, and
damaged tubules
Osteopontin (OPN), a macrophage adhesive protein
[20], has been shown to be expressed in parietal GEC and
in proximal and distal tubules in various models of glomer-
ular diseases [27, 28]. In the current study, there was
expression of OPN within crescents (Fig. 5). Interestingly,
OPN expression was also increased in some visceral GECs
of damaged glomeruli (not shown). There was also an
increased expression of OPN in renal tubules, particularly
in the areas of tubulointerstitial damage (Fig. 5C). Inter-
stitial macrophage infiltration was associated with the areas
of increase tubular OPN expression.
Complement depletion does not prevent the development
of crescents
After CVF treatment, mice had complete depletion of
C3 at days 3 and 7 of disease (0% of standard control,
Fig. 3. Cellular composition of glomerular crescents. (A) At day 7
macrophages are localized in periglomerular and interstitial areas but
are absent in crescents (3630, immunoperoxidase). (B) At day 7 of
disease, CD4 positive T lymphocytes are rarely identified in periglo-
merular areas (arrow) but are absent in the crescents (3630, immu-
noperoxidase). (C) In the normal mouse, the cytoskeletal protein,
ezrin, is expressed in visceral and parietal GECs, and in the brush
borders of renal tubular cells (3630). (D) In crescentic nephritis, ezrin
is expressed within the crescents (arrows) (3630). (E) By double
staining many of the ezrin positive cells (red cytoplasm) also express
the proliferation marker, PCNA (arrows, brown nuclei; 3630).
Table 4. Urinary protein excretion in murine crescentic nephritis (mg/d




Normal 2.4 6 1.5
Day 7 45.4 6 17.3a
Day 14 43.0 6 29.7a
Day 28 72.3 6 59.3a
a P , 0.02 vs. normal
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Table 5) while saline-treated mice had a mild decrease of
C3 at day 3 (60 6 22% of standard control) and normal C3
at day 7 (102 6 44% of standard control). CVF-treated
mouse kidneys had no C3 deposition by immunofluores-
cence at days 3 and 7, whereas control mouse kidneys had
mild C3 deposition at day 3 and moderate C3 deposition at
day 7 (Table 5). However, there was no difference in the
percentage of crescents between CVF-treated and saline-
treated mice (Table 5).
DISCUSSION
In this study we describe a passive model of nephrotoxic
nephritis induced in mice by the injection of a sheep
antibody to rabbit glomeruli. The model results in severe
glomerular and tubulointerstitial injury, with proteinuria,
crescent formation and the progressive development of
glomerulosclerosis and tubulointerstitial fibrosis.
Several interesting findings were observed in this study.
The first major finding was that the early crescent forma-
tion observed at days 7 and 14 appeared to be primarily due
to a proliferation of intrinsic glomerular cells. No macro-
phages, CD4 positive T cells or CD8 positive T cells could
be detected in the lesions (as documented by immunocyto-
chemistry) during this time. Similarly, the crescents were
negative for a-smooth muscle actin, a marker of myofibro-
blasts [17, 29]. Nevertheless, numerous myofibroblasts and
Fig. 4. Crescentic glomerulonephritis is associated with tubulointerstitial injury. (A) There was a marked increase in PCNA-positive cells in the
tubulointerstitium at day 7 (3200). (B) Macrophages (3400) and (C) CD41 T lymphocytes (3200) were the major cellular components of the
periglomerular and interstitial infiltrates at day 7. (D) Cell expressing of a-smooth muscle actin were also identified in areas of interstitial injury (3400).
(E) Type IV collagen and (F) laminin were also increased in interstitial areas by immunostaining at day 28 of disease (arrows) (3630).
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macrophages could be documented surrounding the glo-
meruli outside Bowman’s capsule (Figs. 2B and 3A).
Most of the cells within the crescent were shown to be
proliferating (as noted by the PCNA staining) and to be
positive for the cytoskeletal protein ezrin. Ezrin is an
actin-binding cytoskeletal protein that is expressed by both
visceral and parietal GEC but not by mesangial or endo-
thelial cells [18]. The observation that most of these cells
were ezrin-positive is consistent with them being of either
parietal or visceral origin, and is consistent with reports
that parietal GEC constitutes a major component of cres-
cents [11].
Many of these ezrin positive cells within the crescent
were expressing the PDGF receptor b-subunit. We have
previously reported that human parietal GEC express the
PDGF receptor [25], whereas visceral GEC lack PDGF
receptors and do not respond to PDGF [30]. Furthermore,
two groups have reported that PDGF B-chain mRNA and
protein are expressed in crescents [31, 32]. This suggests
that local PDGF could be involved in the initial crescent
formation.
Another interesting finding was that osteopontin was
expressed within the crescents, an observation that has also
been recently reported by Lan et al [28]. Osteopontin is an
adhesive protein for a variety of cell types including mac-
rophages [33, 34]. In models of tubulointerstitial injury,
osteopontin is expressed by injured tubules, and the degree
and site of osteopontin expression correlates with the
macrophage infiltration [20]. Mice lacking the osteopontin
gene (so-called ‘knockout’ mice) develop less tubulointer-
stitial inflammation and macrophage accumulation after
ureteral obstruction as compared to control mice [35]. This
suggests that osteopontin expression in vivo may have a role
in macrophage accumulation.
However, in this model osteopontin was expressed in the
crescents despite no accumulation of macrophages. One
possible explanation is that the macrophages do not have
access to Bowman’s space in the early period of crescent
fomation. Studies by Bonsib suggest that crescentic nephri-
tis can result in areas of GBM rupture which might allow
access of some leukocytes into Bowman’s space [36], but
this could be a late finding. Another mechanism by which
macrophages and fibroblasts could enter into Bowman’s
space would be through breaks in Bowman’s capsule [37].
Once the Bowman’s capsule is ruptured, large numbers of
macrophages have been documented in the crescents [38].
Some of the macrophage accumulation is also due to local
macrophage proliferation [39].
The observation that the initial crescent formation was
devoid of macrophages and T cells does not imply that this
phase of crescent formation was independent of these cells,
as these cells could be influencing the behavior of the
parietal and visceral GEC via the release of cytokines and
other proinflammatory molecules. Indeed, several studies
have shown that crescent formation is mediated by leuko-
cyte adhesion molecules [40] and specific T cell populations
[41, 42].
In conclusion, we report a model of crescentic nephritis
in the mouse. The early formation of crescents in this
model appeared to be due to a proliferation of intrinsic
Fig. 5. Osteopontin (OPN) expression in crescentic glomerulonephritis.
Normal mice express OPN in some tubules. (A; 3200) In nephrotoxic
nephritis, OPN is expressed in both glomerular crescents (arrows) (B;
3630, day 7) and is increased in tubules at sites of injury (C; 3200, day 7).
Table 5. Effects of complement depletion (CVF) in murine crescentic
nephrotoxic nephritis
CVF-treated mice Saline-treated mice
Serum mouse C3 levels
% of standard
day 3 0 60 6 21.52
day 7 0 101.67 6 43.19
Mouse C3 deposition in
the glomeruli at day 7
(0–41)
0 111 2 1111
Crescents at day 7 (%) 27.0 6 3.54a 27.8 6 3.78a
a P . 0.05
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glomerular (most likely parietal or visceral GEC) cells and
is associated with local PDGF receptor expression. Despite
the local expression of the macrophage adhesive factor,
osteopontin, no macrophages and T cells could be identi-
fied during the early phase of crescent formation. This may
be due to the fact that at this stage of the lesion (before a
documentable rupture of Bowman’s capsule), the macro-
phages and T cells have limited access into this sequestered
space.
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APPENDIX
Abbreviations used in this article are: CVF, cobra venom factor; GBM,
glomerular basement membrane; GEC, glomerular epithelial cells; GN,
glomerulonephritis; Ig, immunoglobulin; OPN, osteopontin; PCNA, pro-
liferating cell nuclear antigen; PDGF-R b, platelet-derived growth factor
receptor b-subunit; RPGN, rapidly progressive glomerulonephritis; TBM,
tubular basement membrane.
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